Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

pradimicin FA 2

Known as: D-Serine, N-((5-((4-amino-4,6-dideoxy-3-O-beta-D-xylopyranosyl-beta-D-galactopyranosyl)oxy)-5,6,8,13-tetrahydro-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo(a)naphthacen-2-yl)carbonyl)-, (5S-trans)-, pradimicin FA-2 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
DNA-damaging agents are widely used in cancer therapy; however, their use is limited by dose-related toxicities, as well as the… Expand
  • table 1
  • table 2
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2000
2000
In order to clarify the mechanism of the calcium-activated anti-fungal action of pradimicin derivatives, we investigated the… Expand
Is this relevant?
1999
1999
The pradimicins are a new class of antifungal agents with activity against the majority of human fungal pathogens. In this study… Expand
Is this relevant?
1999
1999
The dynamic structure of the antifungal antibiotic pradimicin BMY-28864 in D2O and its interaction with calcium ions were… Expand
Is this relevant?
1998
1998
Pradimicin BMY-28864 (Pm) is an antibiotic effective against yeasts and fungi, and is known to bind mannose in the presence of… Expand
Is this relevant?
1993
1993
Several pradimicin-family antibiotics have recently been found to possess potent antifungal activity, while their aglycones are… Expand
  • figure 1
  • table 1
  • table 3
  • table 2
  • table 4
Is this relevant?
1990
1990
Pradimicin FA-1 was produced via directed biosynthesis with substitution of D-serine for D-alanine in the 15-position of… Expand
Is this relevant?